13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
Although news outlets may be preoccupied with alarming updates about the spread of coronavirus – in...
Read More >
The Court of Appeal in Group Seven Limited v. Notable Services LLP [2019] EWCA Civ 614 has agreed wi...
Read More >
The close of the decade ended with a flurry of activity on the labor and employment front, creating ...
Read More >
Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by a new coronavirus, which has ...
Read More >
I’m wary of self-directed brokerage account because I still concerned about the fiduciary issues, a...
Read More >
Protection of privacy in employment relationships: the case for Costa Rica - Why Should You Conside...
Read More >